Review
Jul 2026
Translational cell fate reprogramming and regenerative medicine enabled by microphysiological systems.
This review discusses how organoids and OoC-based platforms are being leveraged to study and enhance cell fate reprogramming, repair, and regeneration across multiple tissues and outlines current limitations, including scalability, standardization, and biomaterial constraints.
Hrithiha Sriramulu, Hyunsung Woo, Anavi Kaul et al.
· Current Opinion in Genetics... · 1 citation